- Home
- HEPA vs AMBO Comparison
HEPA vs AMBO Comparison
Compare HEPA & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- AMBO
- Stock Information
- Founded
- HEPA 2013
- AMBO 2000
- Country
- HEPA United States
- AMBO United States
- Employees
- HEPA N/A
- AMBO N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- AMBO Other Consumer Services
- Sector
- HEPA Health Care
- AMBO Real Estate
- Exchange
- HEPA Nasdaq
- AMBO Nasdaq
- Market Cap
- HEPA 4.7M
- AMBO 5.0M
- IPO Year
- HEPA N/A
- AMBO 2010
- Fundamental
- Price
- HEPA $0.68
- AMBO $1.40
- Analyst Decision
- HEPA Hold
- AMBO
- Analyst Count
- HEPA 1
- AMBO 0
- Target Price
- HEPA N/A
- AMBO N/A
- AVG Volume (30 Days)
- HEPA 39.0K
- AMBO 26.1K
- Earning Date
- HEPA 11-26-2024
- AMBO 11-29-2024
- Dividend Yield
- HEPA N/A
- AMBO N/A
- EPS Growth
- HEPA N/A
- AMBO N/A
- EPS
- HEPA N/A
- AMBO N/A
- Revenue
- HEPA N/A
- AMBO $9,163,000.00
- Revenue This Year
- HEPA N/A
- AMBO N/A
- Revenue Next Year
- HEPA N/A
- AMBO N/A
- P/E Ratio
- HEPA N/A
- AMBO N/A
- Revenue Growth
- HEPA N/A
- AMBO N/A
- 52 Week Low
- HEPA $0.55
- AMBO $1.00
- 52 Week High
- HEPA $4.47
- AMBO $6.30
- Technical
- Relative Strength Index (RSI)
- HEPA 52.88
- AMBO 43.73
- Support Level
- HEPA $0.60
- AMBO $1.33
- Resistance Level
- HEPA $0.68
- AMBO $1.45
- Average True Range (ATR)
- HEPA 0.05
- AMBO 0.16
- MACD
- HEPA 0.00
- AMBO -0.03
- Stochastic Oscillator
- HEPA 87.80
- AMBO 30.00
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.